Cited by 69

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Differential recognition of a dileucine-based sorting signal by AP-1 and AP-3 reveals a requirement for both BLOC-1 and AP-3 in delivery of OCA2 to melanosomes

Sitaram, Anand, Dennis, Megan K., Chaudhuri, Rittik, De Jesus-Rojas, Wilfredo, Tenza, Danièle, Setty, Subba Rao Gangi, Wood, Christopher S., Sviderskaya, Elena V., Bennett, Dorothy C., Raposo, Graça, Bonifacino, Juan S., Marks, Michael S.·2012·Molecular Biology of the Cell

Abstract

Cell types that generate unique lysosome-related organelles (LROs), such as melanosomes in melanocytes, populate nascent LROs with cargoes that are diverted from endosomes. Cargo sorting toward melanosomes correlates with binding via cytoplasmically exposed sorting signals to either heterotetrameric adaptor AP-1 or AP-3. Some cargoes bind both adaptors, but the relative contribution of each adaptor to cargo recognition and their functional interactions with other effectors during transport to melanosomes are not clear. Here we exploit targeted mutagenesis of the acidic dileucine–based sorting signal in the pigment cell–specific protein OCA2 to dissect the relative roles of AP-1 and AP-3 in transport to melanosomes. We show that binding to AP-1 or AP-3 depends on the primary sequence of the signal and not its position within the cytoplasmic domain. Mutants that preferentially bound either AP-1 or AP-3 each trafficked toward melanosomes and functionally complemented OCA2 deficiency, but AP-3 binding was necessary for steady-state melanosome localization. Unlike tyrosinase, which also engages AP-3 for optimal melanosomal delivery, both AP-1– and AP-3–favoring OCA2 variants required BLOC-1 for melanosomal transport. These data provide evidence for distinct roles of AP-1 and AP-3 in OCA2 transport to melanosomes and indicate that BLOC-1 can cooperate with either adaptor during cargo sorting to LROs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1091/mbc.e11-06-0509

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The partial reduction in crystal formation in rab32a and ap3m2 mutants is consistent with known redundancy and compensatory trafficking pathways in LRO biology.

    “The phenotypes we observed for rab32a and ap3m2 mutants show partial yet statistically significant reduction in crystal formation, a feature that is consistent with known redundancy and compensatory trafficking pathways in LRO biology (41, 48, 89).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. Bennett DC, 2003, Pigment Cell Res, 16, 333, 10.1034/j.1600-0749.2003.00067.x · DOI
  2. 10.1091/mbc.12.10.2907 · DOI
  3. Bonifacino JS, 2003, Annu Rev Biochem, 72, 395, 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
  4. Borner GH, 2006, J Cell Biol, 175, 571, 10.1083/jcb.200607164 · DOI
  5. Bultema JJ, 2012, J Biol Chem, 287, 19550, 10.1074/jbc.M112.351908 · DOI · Paper page
  6. Calvo PA, 1999, J Biol Chem, 274, 12780, 10.1074/jbc.274.18.12780 · DOI
  7. Chapuy B, 2008, Traffic, 9, 1157, 10.1111/j.1600-0854.2008.00745.x · DOI
  8. Chaudhuri R, 2007, J Virol, 81, 3877, 10.1128/JVI.02725-06 · DOI
  9. Chaudhuri R, 2009, J Virol, 83, 2518, 10.1128/JVI.02227-08 · DOI
  10. 10.1091/mbc.e07-12-1239 · DOI
  11. Cuomo M, 1991, J Invest Dermatol, 96, 446, 10.1111/1523-1747.ep12470092 · DOI
  12. Darsow T, 1998, J Cell Biol, 142, 913, 10.1083/jcb.142.4.913 · DOI
  13. Delevoye C, 2009, J Cell Biol, 187, 247, 10.1083/jcb.200907122 · DOI
  14. Dell'Angelica EC, 2000, FASEB J, 14, 1265, 10.1096/fj.14.10.1265 · DOI · Paper page
  15. Dell'Angelica EC, 1999, Mol Cell, 3, 11, 10.1016/S1097-2765(00)80170-7 · DOI
  16. Di Pietro SM, 2005, Traffic, 6, 525, 10.1111/j.1600-0854.2005.00299.x · DOI
  17. 10.1091/mbc.e06-05-0379 · DOI
  18. Doray B, 2008, Traffic, 9, 1551, 10.1111/j.1600-0854.2008.00786.x · DOI
  19. 10.1091/mbc.e07-01-0012 · DOI
  20. Feng L, 1999, Hum Mol Genet, 8, 323, 10.1093/hmg/8.2.323 · DOI
  21. Geisler C, 1998, J Biol Chem, 273, 21316, 10.1074/jbc.273.33.21316 · DOI
  22. Gokhale A, 2012, J Neurosci, 32, 3697, 10.1523/JNEUROSCI.5640-11.2012 · DOI · Paper page
  23. Hearing VJ, 2005, J Dermatol Sci, 37, 3, 10.1016/j.jdermsci.2004.08.014 · DOI
  24. Higuchi R, 1988, Nucleic Acids Res, 16, 7351, 10.1093/nar/16.15.7351 · DOI
  25. Höning S, 1998, EMBO J, 17, 1304, 10.1093/emboj/17.5.1304 · DOI
  26. Hoyle DJ, 2011, Pigment Cell Melanoma Res, 24, 275, 10.1111/j.1755-148X.2010.00815.x · DOI
  27. Huizing M, 2008, Annu Rev Genomics Hum Genet, 9, 359, 10.1146/annurev.genom.9.081307.164303 · DOI
  28. 10.1091/mbc.12.7.2075 · DOI
  29. Janvier K, 2003, J Cell Biol, 163, 1281, 10.1083/jcb.200307157 · DOI
  30. Kantheti P, 1998, Neuron, 21, 111, 10.1016/S0896-6273(00)80519-X · DOI
  31. Kelly BT, 2008, Nature, 456, 976, 10.1038/nature07422 · DOI
  32. King RA, 1998, The Pigmentary System: Physiology and Pathophysiology, 553
  33. 10.1091/mbc.e11-07-0592 · DOI
  34. Lee HH, 2012, J Biol Chem, 287, 5882, 10.1074/jbc.M111.325746 · DOI
  35. Lee ST, 1995, Genomics, 26, 354, 10.1016/0888-7543(95)80220-G · DOI
  36. Lepage S, 2006, Cancer Res, 66, 2423, 10.1158/0008-5472.CAN-05-2516 · DOI
  37. Marks MS, 2001, Nat Rev Mol Cell Biol, 2, 738, 10.1038/35096009 · DOI
  38. Mattera R, 2011, J Biol Chem, 286, 2022, 10.1074/jbc.M110.197178 · DOI
  39. Meng R, 2012, Blood, 120, 404, 10.1182/blood-2011-11-389551 · DOI
  40. Mengel-From J, 2010, Forensic Sci Int Genet, 4, 323, 10.1016/j.fsigen.2009.12.004 · DOI
  41. 10.1091/mbc.e08-05-0456 · DOI
  42. Peden AA, 2004, J Cell Biol, 164, 1065, 10.1083/jcb.200311064 · DOI
  43. Pond L, 1995, J Biol Chem, 270, 19989, 10.1074/jbc.270.34.19989 · DOI
  44. Raposo G, 2007, Nat Rev Mol Cell Biol, 8, 786, 10.1038/nrm2258 · DOI
  45. Richmond B, 2005, J Invest Dermatol, 124, 420, 10.1111/j.0022-202X.2004.23585.x · DOI
  46. Rinchik EM, 1993, Nature, 361, 72, 10.1038/361072a0 · DOI
  47. Robila V, 2008, J Immunol, 181, 7843, 10.4049/jimmunol.181.11.7843 · DOI
  48. Robinson MS, 2004, Trends Cell Biol, 14, 167, 10.1016/j.tcb.2004.02.002 · DOI
  49. Rohrer J, 1996, J Cell Biol, 132, 565, 10.1083/jcb.132.4.565 · DOI
  50. 10.1091/mbc.e06-02-0103 · DOI
  51. Salazar G, 2009, J Biol Chem, 284, 1790, 10.1074/jbc.M805991200 · DOI
  52. Setty SR, 2008, Nature, 454, 1142, 10.1038/nature07163 · DOI
  53. 10.1091/mbc.e06-12-1066 · DOI
  54. Simmen T, 1999, J Cell Sci, 112, 45, 10.1242/jcs.112.1.45 · DOI
  55. Sitaram A, 2012, Physiology (Bethesda), 27, 85
  56. 10.1091/mbc.e08-07-0710 · DOI
  57. Starcevic M, 2004, J Biol Chem, 279, 28393, 10.1074/jbc.M402513200 · DOI
  58. Sviderskaya EV, 1997, J Invest Dermatol, 108, 30, 10.1111/1523-1747.ep12285621 · DOI
  59. Sviderskaya EV, 2002, J Natl Cancer Inst, 94, 446, 10.1093/jnci/94.6.446 · DOI
  60. 10.1091/mbc.e06-01-0081 · DOI
  61. 10.1091/mbc.e05-07-0626 · DOI · Paper page
  62. Vijayasaradhi S, 1995, J Cell Biol, 130, 807, 10.1083/jcb.130.4.807 · DOI
  63. Wei ML, 2006, Pigment Cell Res, 19, 19, 10.1111/j.1600-0749.2005.00289.x · DOI
  64. White S, 1998, J Biol Chem, 273, 14355, 10.1074/jbc.273.23.14355 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sitaram, A., Dennis, M. K., Chaudhuri, R., De Jesus-Rojas, W., Tenza, D., Setty, S. R. G., Wood, C. S., Sviderskaya, E. V., Bennett, D. C., Raposo, G., Bonifacino, J. S., & Marks, M. S.
Affiliations
  • Department of Pathology and Laboratory Medicine and Department of Physiology, University of Pennsylvania, Philadelphia, PA 19104
  • Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
  • Section de Recherche, Institut Curie, Unité Mixte de Recherche 144, 75005 Paris, France
  • Biomedical Sciences Research Centre, St. George's, University of London, London SW17 0RE, United Kingdom
Venue
Molecular Biology of the Cell
Published
2012-08-15
Volume
23
Issue
16
Pages
3178-3192
ISSN
  • 1059-1524
  • 1939-4586
Cited by
69
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review